Question 1

What is scheduled for Bristol Myers Squibb on 20 May 2026?

Accepted Answer

On 20 May 2026 Bristol Myers Squibb has internal evaluation/readouts of Claude pilots across research, clinical development, manufacturing, commercial and medical affairs, with triggers including pilot outcome reports, productivity and accuracy metrics, and decisions on wider production use or additional integrations.

Question 2

What did Bristol Myers Squibb say its recently purchased Vera Rubin‑based SuperPOD would achieve?

Accepted Answer

Bristol Myers Squibb said the Vera Rubin‑based SuperPOD would expand the number of candidate molecules evaluated early, shorten timelines to generate trial‑ready molecules, and deliver roughly tenfold more compute per watt versus older systems.

Question 3

How many employees will Bristol Myers Squibb roll out Anthropic Claude to?

Accepted Answer

On 20 May 2026 Bristol Myers Squibb will roll out Anthropic Claude (including Claude Code) to more than 30,000 employees; status: announced/initial deployment; dependencies: systems integration, access to internal data, and security and compliance approvals.

Question 4

What third‑party AI and hardware vendor does Bristol Myers Squibb rely on for DGX SuperPOD systems?

Accepted Answer

Bristol Myers Squibb relies on Nvidia as a third‑party vendor for DGX SuperPOD systems.

Timeline

Bristol Myers Squibb

Big Pharma's AI arms race intensifies as Bristol Myers Squibb hands Anthropic the keys to the enterprise

More in Technology

IP Group leads £4m funding round for AI materials spin-out

Big Technologies faces libel claim from former CEO Sara Murray

Acuity RM Group expands defence programme footprint with new contracts

AdvancedAdvT highlights double-digit growth and strong financial position

Tialis Essential IT lands £7.6m contract, extends public-sector deal

Intercede launches passkey authentication product with public-sector customer

Intercede revenue jumps as first-half trading beats prior year

Vault Ventures' partner signs co-design MoUs with Arqit and Strategic Edge

Oxford Metrics warns on profit as end markets weaken

Oxford Metrics buys Move AI assets to widen Vicon's markerless capture

MedPal AI confirms no equity raise planned as it seeks working capital facility

Browse by Sector

Market reports

Energy & Resources

Financials

Technology

Healthcare

Industrials

Consumer